These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 10811244

  • 1. Antipsychotic drug side effect issues in bipolar manic patients.
    Zarate CA.
    J Clin Psychiatry; 2000; 61 Suppl 8():52-61; discussion 62-3. PubMed ID: 10811244
    [Abstract] [Full Text] [Related]

  • 2. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [Abstract] [Full Text] [Related]

  • 3. Use of atypical antipsychotics in mood disorders.
    Weizman R, Weizman A.
    Curr Opin Investig Drugs; 2001 Jul; 2(7):940-5. PubMed ID: 11757795
    [Abstract] [Full Text] [Related]

  • 4. Two new atypical antipsychotics: advantages and disadvantages.
    Lemon MD.
    S D J Med; 1998 Aug; 51(8):285-6. PubMed ID: 9724957
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania.
    Keck PE.
    J Clin Psychiatry; 2005 Aug; 66 Suppl 3():5-11. PubMed ID: 15762829
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder.
    Guille C, Sachs GS, Ghaemi SN.
    J Clin Psychiatry; 2000 Sep; 61(9):638-42. PubMed ID: 11030483
    [Abstract] [Full Text] [Related]

  • 11. Pharmacotherapy of bipolar disorder: the role of atypical antipsychotics and experimental strategies.
    Malhi GS, Berk M.
    Hum Psychopharmacol; 2002 Dec; 17(8):407-12. PubMed ID: 12457376
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. New treatments for bipolar disorder: the role of atypical neuroleptic agents.
    Ghaemi SN.
    J Clin Psychiatry; 2000 Dec; 61 Suppl 14():33-42. PubMed ID: 11154015
    [Abstract] [Full Text] [Related]

  • 14. Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine.
    Kelly DL, Kreyenbuhl J, Love RC, Van-Duong Q, Conley RR.
    J Clin Psychiatry; 2003 Sep; 64(9):1133-4. PubMed ID: 14628994
    [No Abstract] [Full Text] [Related]

  • 15. Safety in treating bipolar disorder.
    Gupta S.
    J Fam Pract; 2003 Mar; Suppl():S26-9. PubMed ID: 12676082
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of special populations with the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998 Mar; 59 Suppl 12():46-52. PubMed ID: 9766620
    [Abstract] [Full Text] [Related]

  • 19. Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature.
    Peritogiannis V, Tsouli S.
    J Psychopharmacol; 2010 Jul; 24(7):1121-5. PubMed ID: 19395427
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.